Skip to content

PRESS RELEASES


PRESS RELEASES

Date Title and Summary Additional Formats
Toggle Summary Integra LifeSciences Announces Acquisition of the NeuroSensorT Monitor and Related Technology from Novus Monitoring Limited
Integra LifeSciences Announces Acquisition of the NeuroSensorT Monitor and Related Technology from Novus Monitoring Limited Plainsboro, NJ / September 23, 2002 / -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced that it has acquired certain assets, including the
View HTML
Toggle Summary Integra NeuroSciences Announces FDA Clearance to Market the Selector® Integra Ultrasonic Surgical Aspirator for Use in Additional Surgical Procedures
Integra NeuroSciences Announces FDA Clearance to Market the Selector® Integra Ultrasonic Surgical Aspirator for Use in Additional Surgical Procedures Plainsboro, NJ / September 24, 2002/ -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced that Integra NeuroSciences has
View HTML
Toggle Summary Integra NeuroSciences Direct Salesforce Begins Marketing Helitene® Hemostatic Agent in a Pad Form
Integra NeuroSciences Direct Salesforce Begins Marketing Helitene® Hemostatic Agent in a Pad Form Plainsboro, New Jersey, September 24, 2002-- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced that its Integra NeuroSciences division has begun marketing the Helitene®
View HTML
Toggle Summary Integra NeuroSciences Announces Launch of Camino® Single Parameter Monitor in Europe and Other International Markets
Integra NeuroSciences Announces Launch of Camino® Single Parameter Monitor in Europe and Other International Markets Plainsboro, NJ / September 24, 2002/ -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced that Integra NeuroSciences has launched the Camino® Single
View HTML
Toggle Summary Integra LifeSciences Holdings Corporation Appoints David C. Auth to Board of Directors
Integra LifeSciences Holdings Corporation Appoints David C. Auth to Board of Directors Plainsboro, NJ / September 18, 2002 / -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced that effective October 31, 2002 it will increase the size of its Board of Directors to six and
View HTML
Toggle Summary Integra LifeSciences and REVA Medical Announce Agreement for REVA Medical to Evaluate Integra's Tyrosine-Derived Polycarbonates for Use in Cardiovascular Stents
Integra LifeSciences and REVA Medical Announce Agreement for REVA Medical to Evaluate Integra's Tyrosine-Derived Polycarbonates for Use in Cardiovascular Stents PLAINSBORO, N.J., Aug. 6, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) and REVA Medical, Inc.
View HTML
Toggle Summary Integra LifeSciences Announces Acquisition of Signature Technologies, a Specialty Manufacturer of Neurosurgical and Spinal Implants
Integra LifeSciences Announces Acquisition of Signature Technologies, a Specialty Manufacturer of Neurosurgical and Spinal Implants PLAINSBORO, N.J. and Pembroke, Mass., Aug. 1, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has acquired the
View HTML
Toggle Summary Integra LifeSciences Acquires Neurosciences Division of NMT Medical; Acquisition Signals Continued Expansion of Integra's Neuroscience Business
Integra LifeSciences Acquires Neurosciences Division of NMT Medical; Acquisition Signals Continued Expansion of Integra's Neuroscience Business PLAINSBORO, N.J., Aug. 1, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has acquired the
View HTML
Toggle Summary Integra LifeSciences Reports Second Quarter Earnings Per Share of $0.14 on Record Revenues of $26.4 Million
Integra LifeSciences Reports Second Quarter Earnings Per Share of $0.14 on Record Revenues of $26.4 Million PLAINSBORO, N.J., Aug. 1, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today reported record revenues of $26.4 million and net income of $0.14 per share for the
View HTML
Toggle Summary Integra LifeSciences Schedules Conference Call for Tuesday, August 6 to Discuss Second Quarter 2002 Financial Results and Update Forward-Looking Financial Guidance; Announces Participation in Adams, Harkness & Hill Annual Summer Seminar
Integra LifeSciences Schedules Conference Call for Tuesday, August 6 to Discuss Second Quarter 2002 Financial Results and Update Forward-Looking Financial Guidance; Announces Participation in Adams, Harkness & Hill Annual Summer Seminar PLAINSBORO, N.J.-July 29, 2002-- Integra LifeSciences Holdings
View HTML
Toggle Summary Recently Approved Spinal Fusion Device and Bone Graft Using Genetically Engineered Protein Utilizes Integra LifeSciences' Absorbable Collagen Sponge
Recently Approved Spinal Fusion Device and Bone Graft Using Genetically Engineered Protein Utilizes Integra LifeSciences' Absorbable Collagen Sponge Plainsboro, New Jersey, July 15, 2002-- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced that its Absorbable Collagen Sponge
View HTML
Toggle Summary Integra LifeSciences Reports First Quarter Earnings Per Share of $0.13 on Record Revenues of $25.9 Million
Integra LifeSciences Reports First Quarter Earnings Per Share of $0.13 on Record Revenues of $25.9 Million PLAINSBORO, N.J., May 8, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today reported record revenues of $25.9 million and net income of $0.13 per share for the
View HTML
Toggle Summary Integra LifeSciences Announces FDA Approval to Market INTEGRA Dermal Regeneration Template for the Repair of Scar Contractures
Integra LifeSciences Announces FDA Approval to Market INTEGRA Dermal Regeneration Template for the Repair of Scar Contractures PLAINSBORO, N.J., April 23, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced that the U.S.
View HTML
Toggle Summary Integra NeuroSciences Announces FDA Clearance to Market a Tunneled Catheter for the LICOX Brain Tissue Oxygen Monitoring System; Product Launch to Begin in Second Quarter
Integra NeuroSciences Announces FDA Clearance to Market a Tunneled Catheter for the LICOX Brain Tissue Oxygen Monitoring System; Product Launch to Begin in Second Quarter PLAINSBORO, N.J., April 9, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that
View HTML
Toggle Summary Integra LifeSciences Reports Preliminary First Quarter 2002 Revenues; Forward-Looking Earnings Guidance Unchanged
Integra LifeSciences Reports Preliminary First Quarter 2002 Revenues; Forward-Looking Earnings Guidance Unchanged PLAINSBORO, N.J., April 5, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) today reported preliminary revenues for the first quarter ended March 31, 2002.
View HTML